So the RNAi analyst says BLT has got nothing and will just run...

So the RNAi analyst says BLT has got nothing and will just run of of cash and go bankrupt next year. You can't argue with this perception with a market cap sinking faster than its cash balance. Pretty obvious the market doesn't trust the current management or believe a deal will be made. Is the latest data good enough for a partner?

The new CEO has to to define the true level of interest from big pharma and state it as the No.1 priority (after getting rid of of the sponge Stubbings). The company cannot wait.

As with the in vitro data the HBV data resulted in a pump and dump - 40% spike all retraced. T+2 traders burnt, not that I care about that, but the rally didn't get past half a day.

Next announcement I assume is a new CEO, followed by the US roadshow.